Mustafa Noor
Plus aucun poste en cours
Profil
Mustafa Noor worked as the Chief Development Officer at Akcea Therapeutics, Inc. from 2017 to 2018.
Anciens postes connus de Mustafa Noor
| Sociétés | Poste | Fin |
|---|---|---|
| AKCEA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2018 |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Akcea Therapeutics, Inc.
 Akcea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Akcea Therapeutics, Inc. is a biopharmaceutical company. It engages in the development and marketing of drugs globally to treat patients with rare and serious diseases using antisense technology. Its primary focus is developing TEGSEDI, a therapy that treats the polyneuropathy caused by hereditary transthyretin-mediated amyloidosis in adults. It also offers a mature pipeline of novel drugs including AKCEA-APO(a)-LRx, AKCEA-ANGPTL3-LRx, and AKCEA-APOCIII-LRx. The company was founded in December 2014 and is headquartered in Cambridge, MA. | Health Technology |
